All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-20532178
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 20532178 A71T
PR
gag-pol
HIV Infections
D
G
C
L
T
View
2 20532178 D60E
PR
gag-pol
HIV Infections
D
G
C
L
T
View
3 20532178 D67G
RT
gag-pol
HIV Infections
D
G
C
L
T
View
4 20532178 D67N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
5 20532178 G190A
RT
gag-pol
HIV Infections
D
G
C
L
T
View
6 20532178 H69K
PR
gag-pol
HIV Infections
D
G
C
L
T
View
7 20532178 I13V
PR
gag-pol
HIV Infections
D
G
C
L
T
View
8 20532178 I62V
PR
gag-pol
HIV Infections
D
G
C
L
T
View
9 20532178 I64L
PR
gag-pol
HIV Infections
D
G
C
L
T
View
10 20532178 I64V
PR
gag-pol
HIV Infections
D
G
C
L
T
View
11 20532178 I84V
PR
gag-pol
HIV Infections
D
G
C
L
T
View
12 20532178 I85V
PR
gag-pol
HIV Infections
D
G
C
L
T
View
13 20532178 I93L
PR
gag-pol
HIV Infections
D
G
C
L
T
View
14 20532178 K103N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
15 20532178 K103R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
16 20532178 K20M
PR
gag-pol
HIV Infections
D
G
C
L
T
View
17 20532178 K20R
PR
gag-pol
HIV Infections
D
G
C
L
T
View
18 20532178 K20V
PR
gag-pol
HIV Infections
D
G
C
L
T
View
19 20532178 K219N
RT
gag-pol
HIV Infections
D
G
C
L
T
View
20 20532178 K219Q
RT
gag-pol
HIV Infections
D
G
C
L
T
View
21 20532178 K43T
PR
gag-pol
HIV Infections
D
G
C
L
T
View
22 20532178 K65R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
23 20532178 K70R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
24 20532178 L10F
PR
gag-pol
HIV Infections
D
G
C
L
T
View
25 20532178 L10I
PR
gag-pol
HIV Infections
D
G
C
L
T
View
26 20532178 L10R
RT
gag-pol
HIV Infections
D
G
C
L
T
View
27 20532178 L210W
RT
gag-pol
HIV Infections
D
G
C
L
T
View
28 20532178 L63P
PR
gag-pol
HIV Infections
D
G
C
L
T
View
29 20532178 L90M
PR
gag-pol
HIV Infections
D
G
C
L
T
View
30 20532178 M184I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
31 20532178 M184V
RT
gag-pol
HIV Infections
D
G
C
L
T
View
32 20532178 M36I
PR
gag-pol
HIV Infections
D
G
C
L
T
View
33 20532178 M41L
RT
gag-pol
HIV Infections
D
G
C
L
T
View
34 20532178 M46I
PR
gag-pol
HIV Infections
D
G
C
L
T
View
35 20532178 Q58E
PR
gag-pol
HIV Infections
D
G
C
L
T
View
36 20532178 T215C
RT
gag-pol
HIV Infections
D
G
C
L
T
View
37 20532178 T215F
RT
gag-pol
HIV Infections
D
G
C
L
T
View
38 20532178 T215Y
RT
gag-pol
HIV Infections
D
G
C
L
T
View
39 20532178 V179D
RT
gag-pol
HIV Infections
D
G
C
L
T
View
40 20532178 V32I
PR
gag-pol
HIV Infections
D
G
C
L
T
View
41 20532178 V75A
RT
gag-pol
HIV Infections
D
G
C
L
T
View
42 20532178 V77I
PR
gag-pol
HIV Infections
D
G
C
L
T
View
43 20532178 V82I
PR
gag-pol
HIV Infections
D
G
C
L
T
View
44 20532178 Y118I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
45 20532178 Y181C
RT
gag-pol
HIV Infections
D
G
C
L
T
View
46 20532178 Y181I
RT
gag-pol
HIV Infections
D
G
C
L
T
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.